Company / EPS (Diluted)
Co-Diagnostics, Inc. EPS (Diluted) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$37.22
FY2025
5-year range
-$37.22 / $1.52
FY2021-FY2025
Trend
-3001.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -3002% YoY in FY2025, a notable deviation from the 7-year average annual change of -395%.
Based on SEC 10-K filings.
-37.22 in FY2025.
Declined from $-0.45 to $-37.22 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Co-Diagnostics, Inc.'s eps (diluted) has declined for 4 consecutive years.
- In FY2025, eps (diluted) decreased 3001.7% year-over-year.
- Peak eps (diluted) was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$37.22 | -3001.7% |
| FY2024 | -$1.20 | -166.7% |
| FY2023 | -$0.45 | -136.6% |
| FY2022 | $1.23 | -19.1% |
| FY2021 | $1.52 | +510.8% |
| FY2020 | -$0.37 | +26.0% |
| FY2019 | -$0.50 | +20.6% |
| FY2018 | -$0.63 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026